TA-1887 - CAS 1003005-29-5

TA-1887 is a new type of selective inhibitor of sglt2 for the treatment of type 2 diabetes. It has a significant hypoglycemic effect in KK (HF-KK) mice fed a high-fat diet. TA-1887 has good pharmacokinetic characteristics and significantly increases UGE

Others, SGLT

GPCR/G Protein, Others

1002971

C24H26FNO5

427.47

O[C@H]1[C@H](N2C=3C(C(CC4=CC=C(C=C4)C5CC5)=C2)=C(F)C=CC3)O[C@H](CO)[C@@H](O)[C@@H]1O

-20°C

Ice Packs

Small Compound